期刊文献+

石斛酚与丁香酸的ADMET分子模拟预测 被引量:1

The pharmacokinetics of gigantol and syringic acid
下载PDF
导出
摘要 目的分子模拟预测石斛酚与丁香酸的吸收、分布、代谢、排泄和毒理性(ADMET),为进一步开发研究奠定基础。方法采用DS2.1中ADMET模块,从吸收性、水溶性、血脑屏障穿透性、与人细胞色素P450 2D6酶结合、肝毒性、与血浆蛋白结合6个方面进行测定。结果石斛酚的肝毒性比标准稍高,石斛酚与丁香酸的其他各方面的预测值都在正常范围内。结论石斛酚、丁香酸的ADMET测定结果符合药物研究开发的标准,可作为新药进一步研究。 Objective To predict the pharmacokinetics(ADMET) of gigantol and syringic acid by molecular modeling,and to lay the foundation for further research and development.Methods The module of DS2.1 in ADMET was used.Six aspects including the passive absorption,the aqueous solubility,the blood-brain barrier penetration,the cytochrome P450 2D6(CYP2D6),the hepatotoxicity interactive abretry and the plasma protein binding were measured.Result The liver toxicity of gigantol was slightly higher than the standard and the others predicted values were within the normal range of gigantol and syringic acid.Conclusion The ADMET prediction result of gigantol and syringic acid show that the two compounds meet the standards of drug research,which can be used to guide the rational design of more potent new drugs.
出处 《西北药学杂志》 CAS 2011年第3期211-213,共3页 Northwest Pharmaceutical Journal
基金 国家自然科学基金(编号:30850012) 广东省自然科学基金项目(编号:06024128) 广东省科技计划项目(编号:2007B020704005 2009B060700070 2009B090300335 2009A030100003)
关键词 石斛酚 丁香酸 ADMET Gigantol syringic acid ADMET
  • 相关文献

参考文献14

  • 1Grossman I. ADME pharmacogenetics:current practices and future outlook[J]. Expert Opin Drug Metab Toxicol,2009,5 : 449-462.
  • 2Van de Waterbeemd H, Giffoed E. ADMET in silieo modelling: towards prediction paradise. [J]. Nat Drug Dis, 2003,2 : 192-204.
  • 3Hilmer SN. ADMET-tox issues for the elderly[J]. Expert Opin Drug Metab Toxicol, 2008,4 : 1321-1331.
  • 4Kennedy T. Managing the drug discovery/development interface[J]. Drug Disc Today, 1997,2 :436-444.
  • 5Jamei M, Dickinson GL, Rostami-Hodjegan. A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of' bottom-up ' vs 'top-down' recognition of covariates[J]. Drug Metab Pharmacokinet, 2009,24: 53-75.
  • 6Wang Z, Ling B, Zhang R, et al. Docking and molecular dynamics studies toward the binding of new natural phenolic marine inhibitors and aldose reductase[J]. Mol Graph Model, 2009,28 .. 162-169.
  • 7Janssen D. The power of prediction[J]. Drug Disc,2002, 1(11) :38-40.
  • 8Carlson TJ, Segall MD. Predictive, computational models of ADME properties[J].Curr Drug Disc, 2002,5 (1) : 34- 36.
  • 9Podlogar BL, Muegge I, Brice LJ. Computational methods to estimate drug development parameters[J]. Curr Opin Drug Disc Dev, 2001,4 : 102-109.
  • 10Ekins S, Waller CL, Swaan PW, et al. Progress in predicting human ADME parameters in silico[J]. Pharmacol Toxicol Methods, 2001,44 : 251-272.

同被引文献12

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部